XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Equity Compensation and Other Benefit Plans (Tables)
 9 Months Ended
Sep. 30, 2024
Compensation Related Costs [Abstract]  
Schedule of Expenses Related to Equity-Based Compensation
The following table presents the Company’s expenses related to its equity-based compensation instruments for the three and nine months ended September 30, 2024 and 2023:
Three Months Ended
September 30,		Nine Months Ended
September 30,
(In Thousands)2024202320242023
RSUs$2,104 $4,448 $12,247 $11,399 
Total$2,104 $4,448 $12,247 $11,399 
Schedule of Expenses (Reversal) Related to Deferred Compensation Plans The following table presents the Company’s expenses (reversal) related to its Deferred Plans for the three and nine months ended September 30, 2024 and 2023:
 
Three Months Ended
September 30,		Nine Months Ended
September 30,
(In Thousands)2024202320242023
Non-employee directors$574 $(260)$588 $154 
Total$574 $(260)$588 $154 
Schedule of Aggregate Income Deferred by Participants and Associated Liability Under Deferred Compensation Plans
The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through September 30, 2024 and December 31, 2023 that had not been distributed and the Company’s associated liability for such deferrals at September 30, 2024 and December 31, 2023:
 
September 30, 2024December 31, 2023
(In Thousands)
Undistributed Income Deferred (1)
 Liability Under Deferred Plans
Undistributed Income Deferred (1)
 Liability Under Deferred Plans
Non-employee directors$2,689 $3,065 $2,611 $2,404 
Total$2,689 $3,065 $2,611 $2,404 
(1)  Represents the cumulative amounts that were deferred by participants through September 30, 2024 and December 31, 2023, which had not been distributed through such respective date.